LOGIN  |  REGISTER
Chimerix

Ontrak Launches Groundbreaking Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery

May 23, 2024 | Last Trade: US$1.73 0.05 -2.81

MIAMI / May 23, 2024 / Business Wire / Ontrak Inc (NASDAQ: OTRK), a leading AI-powered and technology-enabled healthcare company, today announced the launch of its pioneering Mental Health Digital Twin (MHDT) technology. This innovative advancement in mental health care delivery seamlessly fuses human empathy with data-driven insights to provide personalized, precise, and effective care for individuals struggling with mental health challenges.

Ontrak's MHDT technology creates a comprehensive virtual representation of each unique individual enrolled in the Ontrak Program, leveraging vast amounts of data from various sources, including claims data, clinical assessments, biometric data, patient-reported outcomes and social determinants of health. By processing millions of data points and utilizing advanced AI and machine learning models, the MHDT generates predictive insights and personalized recommendations, which are delivered through Ontrak’s Advanced Engagement System, enabling care teams to make informed decisions and deliver targeted interventions.

"We are thrilled to introduce our Mental Health Digital Twin technology, which represents a significant leap forward in the field of precision mental health care," said Brianna Brennan, Chief Innovation Officer at Ontrak. "By harnessing the power of data and advanced analytics, we are enabling care teams to deliver highly personalized, evidence-based care that adapts to each individual's unique needs and circumstances. Our MHDT technology is not only transforming the way we approach mental health care delivery, but also profoundly impacting the lives of the individuals we serve."

Key features and benefits of Ontrak's MHDT technology include:

  • Proactive identification of high-risk individuals through predictive modeling, facilitating early intervention and preventive care
  • Hyper-personalized care planning based on the MHDT's insights into each individual's unique profile, needs, and preferences
  • Continuous analysis of coach-patient interactions to enhance the quality and impact of coaching, strengthening the therapeutic alliance
  • Integration with Ontrak's care delivery workflows, providing care teams with real-time insights and recommendations to optimize treatment outcomes
  • Acceleration of care innovation by leveraging MHDT data to test novel interventions and uncover best practices

To learn more about Ontrak's Mental Health Digital Twin technology and its transformative potential in precision mental health care delivery, please visit https://ontrakhealth.com/white-papers/ontraks-mental-health-digital-twin-pioneering-personalized-care/.

About Ontrak Health

Ontrak Health (Nasdaq: OTRK) is a leading AI and technology-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB